The group's principal activitity to research, develop, manufacture and market low temperature technologies for use in the cryoablation of cancerous tissue and in preserving and prolonging the viability of cellular and genetic material for use in cell therapy and tissue engineering. The products of the group include accuprobe, single use probes and other disposables used with the accuprobe and also offers service contracts. The group markets accuprobe system through a direct sales force and through distributors to hospitals, surgeons and radiologists in the United States and abroad.
